GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Aidea Pharmaceutical Co Ltd (SHSE:688488) » Definitions » 5-Year Dividend Growth Rate

Jiangsu Aidea Pharmaceutical Co (SHSE:688488) 5-Year Dividend Growth Rate : 0.00% (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Jiangsu Aidea Pharmaceutical Co 5-Year Dividend Growth Rate?

Jiangsu Aidea Pharmaceutical Co's Dividends per Share for the three months ended in Mar. 2025 was ¥0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Jiangsu Aidea Pharmaceutical Co's Dividend Payout Ratio for the three months ended in Mar. 2025 was 0.00. As of today, Jiangsu Aidea Pharmaceutical Co's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Jiangsu Aidea Pharmaceutical Co's 5-Year Dividend Growth Rate

For the Biotechnology subindustry, Jiangsu Aidea Pharmaceutical Co's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Aidea Pharmaceutical Co's 5-Year Dividend Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jiangsu Aidea Pharmaceutical Co's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Jiangsu Aidea Pharmaceutical Co's 5-Year Dividend Growth Rate falls into.


;
;

Jiangsu Aidea Pharmaceutical Co 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Jiangsu Aidea Pharmaceutical Co  (SHSE:688488) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Jiangsu Aidea Pharmaceutical Co's Dividend Payout Ratio for the quarter that ended in Mar. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2025 )/ EPS without NRI (Q: Mar. 2025 )
=0/ 0.018
=0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

During the past 9 years, the highest Dividend Yield of Jiangsu Aidea Pharmaceutical Co was 0.55%. The lowest was 0.19%. And the median was 0.31%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiangsu Aidea Pharmaceutical Co 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of Jiangsu Aidea Pharmaceutical Co's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Aidea Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 2 Liuzhuang Road, Hanjiang District, Jiangsu Province, Yangzhou, CHN, 225008
Jiangsu Aidea Pharmaceutical Co Ltd produces and sells human-derived protein products, and also develops some generic drug businesses and distributes Abbott's HIV diagnostic equipment and reagents. The company focuses on development of new chemical entities of anti-tumor, anti-virus and cardiovascular areas, among which two NCE drugs for the treatment of Cancer and AIDS have been approved.
Executives
Wang Jun Directors, senior managers
Fu He Liang Director, core technical staff
Zhang Jie Directors, senior managers
Yuan Yu Core technical personnel
Su Gu Fang Core technical personnel
Zhang Ji Bing Core technical personnel
Wang Guang Rong Directors, senior managers
Yu Ke Directors, senior managers

Jiangsu Aidea Pharmaceutical Co Headlines

No Headlines